Merck signed a licensing agreement for a heart disease drug with Jiangsu Hengrui Pharmaceuticals worth up to $2 billion.
The US Food and Drug Administration (FDA) has early this week approved GSK's new antibiotic, Blujepa (gepotidacin), for the ...
2d
Pharmaceutical Technology on MSNGSK and UK researchers plan to study Shingrix and dementia risk reduction linkThe study will analyse electronic health records of 65- and 66-year olds from the UK’s National Health Service (NHS).
GSK (GSK) plc announced a new research collaboration with the UK Dementia Research Institute and Health Data Research UK to advance ...
After every meal, the intestines perform an action called peristalsis - moving food through their hollow interiors with coordinated contractions and relaxations of the smooth muscle.
GSK said on Tuesday that it is studying a group of more than a million older adults in the UK to examine whether its ...
Research in mice identifies protein responsible for regulating gut movement in response to pressure, exercise, and ...
The U.S. Food and Drug Administration (FDA) has issued its recommendations to vaccine makers on which virus strains to select when manufacturing influenza (flu) vaccines for the 2025-2026 U.S. flu ...
13th Mar 2025 7:00 am RNS Transaction in Own Shares 12th Mar 2025 7:00 am RNS Transaction in Own Shares 11th Mar 2025 7:00 am RNS Transaction in Own Shares 10th Mar ...
Elizabeth Warren (D-Mass.) is asking a federal watchdog to investigate GSK for replacing a popular asthma inhaler with a so-called authorized generic at a much higher price in order to avoid ...
Our newly-favored stance is based on resumption of deferred medical procedures and significant new quality-of-life drugs and treatments. The category is broad and has underperformed the S&P 500 ...
Multinational pharmaceutical company GSK’s commitment to invest up to $800 million in its facility near Marietta may have gone elsewhere without tax incentives approved by local officials last year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results